TransPerfect
Life Sciences, a leading provider of services and technologies to
support global product development for the life sciences industry, has
released version 1.2 of myTI,
the mobile application that enables real-time eTMF management and
oversight for study teams on the go. This new release of the mobile
version of the Trial
Interactive e-clinical platform simplifies CRA site visits,
providing even more ways to speed timelines and reduce risk.
Simplifying site visits and mobile reconciliation is a key aim of myTI
1.2. The app allows CRAs to perform and record required site visit tasks
directly from a mobile device and features enhanced TMF review and
documentation capabilities, eliminating paper documentation and
time-consuming manual review.
CRAs who use myTI 1.2 will benefit from enhancements that include:
-
Reconciliation Tasks – Complete reconciliation more quickly with
instant access to site files -
Site Visit Reporting – Improve oversight and overall TMF management
with live reporting -
Documentation Access – Remove barriers for CRA handovers,
co-monitoring, and training by accessing documents submitted by any
author -
Query Visibility and Action – Promote proactive TMF management with a
complete query view that makes it easy to review and respond to
queries. Additionally, email notifications link directly to tasks in
myTI to encourage immediate action -
E-Signature Document Approval – Speed document approval with the
convenience of e-signature -
Rejected Documents View – Improve TMF completeness with a real-time
rejected documents view -
Enhanced Support – Access support resources at any time with an online
help manual and in-app contact capabilities for live Trial Interactive
support -
SSO – Eliminate password and login headaches with single sign-on
access to myTI
TransPerfect President and CEO Phil Shawe stated, “Any technology that
simplifies essential site visit tasks is a significant advancement for
those performing global clinical trials. I’d like to thank our CRA and
clinical stakeholder consultants, who were instrumental in shaping this
version of our Trial Interactive mobile application.”
About Trial Interactive
TransPerfect’s Trial Interactive solution provides a collaborative,
web-based platform for clinical development that enables sponsors, CROs,
IRBs, and other vendors to maintain and update clinical trial
documentation in a secure online environment, adhering to global
regulatory requirements. With fully searchable solutions, including
investigator portals, Trial Interactive streamlines study timelines and
reduces the administrative burdens of global clinical trials. As part of
TransPerfect’s Life Sciences division, Trial Interactive is dedicated to
working with clients on a global, collaborative level, supporting a wide
range of requirements, including e-feasibility, study start-up, eTMF
review/reconciliation, mobile applications, learning management and
document management systems, investigator portals, pharmacovigilance and
safety management, and endpoint adjudication. For more information on
Trial Interactive, please contact info@trialinteractive.com
or +1 212.400.8848, or visit www.trialinteractive.com.
About TransPerfect
TransPerfect is
the world’s largest provider of language
services and technology
solutions for global business. From offices in over 90 cities
on six continents, TransPerfect offers a full range of services in 170+
languages to clients worldwide. More than 5,000 global organizations
employ TransPerfect’s GlobalLink® Product
Suite to simplify management of multilingual content. With an
unparalleled commitment to quality and client service, TransPerfect is
fully ISO
9001 and ISO
17100 certified. TransPerfect has global headquarters in New York,
with regional headquarters in London and Hong Kong. For more
information, please visit our website at www.transperfect.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190510005531/en/